Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
      • Neuroimmunology: To Sense and Protect
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • My alerts
  • Log in
  • Log out
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Cutting Edge: Differentiation of Human NK Cells into NK1 and NK2 Subsets

David Peritt, Susan Robertson, Giorgia Gri, Louise Showe, Miguel Aste-Amezaga and Giorgio Trinchieri
J Immunol December 1, 1998, 161 (11) 5821-5824;
David Peritt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan Robertson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giorgia Gri
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Louise Showe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miguel Aste-Amezaga
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giorgio Trinchieri
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Human NK cells cultured in the presence of IL-12 or IL-4 differentiate into cell populations with distinct patterns of cytokine secretion similar to Th1 and Th2 cells. NK cells grown in IL-12 (NK1) produce IL-10 and IFN-γ, whereas NK cells grown in IL-4 (NK2) produce IL-5 and IL-13. Although these NK cell subsets do not differ in cytotoxic activity, NK1 cells express higher levels of cell surface CD95 (Fas) Ag than NK2 cells and are more sensitive to Ab or chemically induced apoptosis. Like Th1 cells, NK1 cells accumulate much higher levels of the IL-12Rβ2-chain mRNA and are significantly more responsive to IL-12 than NK2 cells at the level of activation of STAT4 transcription factor. The identification of NK cell subsets that are analogous to T cell subsets suggests a new role for NK cells in innate inflammatory responses and in their effect on adaptive immunity.

Natural killer cells were considered non-MHC-restricted cytotoxic cells producing type 1 cytokines, such as IFN-γ, TNF-α, granulocyte-macrophage CSF (GM-CSF),3 lymphotoxin (LT), and IL-8 (1). The early migration of IFN-γ-producing NK cells into the inflammatory sites and draining lymph nodes is important in the generation of a Th1 immune response (2). The production of IFN-γ by NK cells has been shown to be enhanced by IL-12, which favors a Th1 response, and inhibited by IL-4, which favors a Th2 response (3). Until the recent demonstration that NK cells can produce IL-5, a Th2 response cytokine (4), the cytokine repertoire of NK cells was thought to be restricted to a type 1 pattern. Secretion of IL-5 by NK cells raised the possibility that NK cells might differentiate into distinct subsets. We report here that NK cells differentiate into two distinct subsets reminiscent of Th1 and Th2 cells, although neither subset produces IL-2 or IL-4. NK2 cells have decreased expression and function of the IL-12R, which is a hallmark of Th2 cells (5). There is no difference in cytotoxic activity of either subset, yet NK1 do express higher levels of CD95 and are more susceptible to apoptotic induction.

Materials and Methods

NK subset generation

NK cells were generated from 13 donors as described (6). PBL (2.5 × 105/ml) were cultured in 24-well plates with 5 × 104 γ-irradiated RPMI 8866 cells in the presence of either 1 ng IL-12 + anti-IL-4 mAb (4F2/5A4) or 50 ng/ml IL-4 + anti-IL-12 mAb (C8.6). At day 8, NK cell subsets were purified by negative selection using mAb anti-CD3, -CD14, -CD21, -CD19, -CD4 to >98% purity as determined by CD16 or CD56 staining. NK cells were stimulated for 18 h with 20 ng/ml PMA and 50 μM ionomycin (106 cells/ml), and cell-free supernatants were tested by RIA for IL-4, IL-5, IL-10, IL-13, IFN-γ, GM-CSF, LT, and TNF-α levels. To determine reversibility of NK subsets, NK cells from 4 donors were washed and placed in the reversing condition (or kept in the same condition) for 4 days, purified, and stimulated as above.

RNase protection assay (RPA)

RNase protection using 10 μg/lane total mRNA was performed using PharMingen (San Diego, CA) multitemplate probe kits (hck1, hApo3, hApo4, and probes generated in our lab). RNA intensity was normalized against internal glyceraldehyde-3-phospate dehydrogenase (GAPDH) band to adjust for loading or RNA harvesting errors.

Electrophoretic mobility shift assay (EMSA)

Nuclear extracts, obtained from purified NK1 and NK2 cells, were incubated overnight in medium with anti-IFN-γ mAb (B133.3), followed by incubation for 20 min with medium alone or with added IL-12. End-labeled gamma-activated site (GAS) DNA probe (5′-AGCTTGTATTTCCCAGAAAAGGGATC-3′), derived from the FcγRI (CD64) promoter (50,000 cpm/sample), was mixed with 4 μg of nuclear extract for 30 min at room temperature. Samples were fractionated on a 4% polyacrylamide gel for 1 h at 200 V. When supershifts were performed, nuclear extracts were preincubated for 30 min at 4°C with 2 μg/ml of polyclonal Abs (anti-STAT1, anti-STAT4, Santa Cruz Biotechnology, Santa Cruz, CA).

Intracellular staining for IFN-γ

NK subsets were generated as described and stimulated for 4 h with 20 ng/ml PMA + 50 μM ionomycin and monensin. These cells were stained with anti-CD56-phycoerythrin (PE) surface labeling and fixed with 4% paraformaldehyde for 30 min, then treated with 0.1% saponin and intracellular stained with anti-IFN-γ-FITC in the presence or absence of 1 μg/ml exogenous rIFN-γ.

CD95 surface expression and NK cell apoptosis

Cultured NK1 and NK2 cells were stained with anti-CD95-FITC (CH-11), anti-CD16 (3G8) biotin/PE-Cy5 streptavidin and anti-CD3-PE (OKT3). Cultured NK1 and NK2 cells were treated for 4 h with medium, anti-CD16 (3G8), or 20 ng PMA + 50 μM ionomycin. These cells were stained with anti-CD56-FITC and propidium iodine (PI), followed by flow cytometry. Alternatively, cells were stained with anti-CD56-PE, fixed in 1% paraformaldehyde/PBS solution for 15 min at room temperature, permeabilized with 0.1% Triton X-100 at 4°C for 2 min, and resuspended in 50 μl terminal deoxynucleotidyltransferase-mediated UTP end labeling (TUNEL) reaction mixture (Boehringer Mannheim, Indianapolis, IN) for 1 h at 37°C.

Results and Discussion

We generated NK cells by coculturing PBLs with irradiated RPMI 8866 cells for 8 days in the presence of either recombinant IL-12 and an anti-IL-4 mAb (NK1 condition) or recombinant IL-4 and an anti-IL-12 mAb (NK2 condition). Upon stimulation of purified NK cells with either plastic-bound anti-CD16 or PMA/ionomycin, cells generated under NK1 conditions produced high levels of IFN-γ, GM-CSF, TNF-α, and LT. Cells grown under NK2 conditions produced similar levels of TNF-α, GM-CSF, and LT, but significantly less IFN-γ, and significantly higher levels of IL-5 and IL-13 (Fig. 1⇓). RPA confirmed the protein findings and showed skewed patterns of cytokine mRNA accumulation in NK1 and NK2 cells. Neither subset expressed detectable mRNA for IL-2, IL-4, IL-14, IL-15, or IL-9 (Fig. 2⇓).

FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

Cytokine production by cultured NK cells. NK cells were generated in the presence of either IL-12 + anti-IL-4 mAb (NK1) or IL-4 + anti-IL-12 mAb (NK2) for 8 days, purified by negative selection to >98% purity, and 106 cells/ml stimulated for 18 h with PMA + ionomycin. Supernatant fluids of NK cells from 13 donors were tested by RIA for IL-5, IL-10, IL-13, IFN-γ, LT, and TNF-α levels (solid bars). After 8-day culture, as above, NK1 and NK2 cells from 4 donors were washed and placed in the reversing condition (or kept in the same condition) for 4 days (NK1 conditions, stippled bars; NK2 conditions, striped bars). Data are given as mean (±SD) cytokine production for all donors tested. Significance of the differences in cytokine production is shown only for the 8-day cultures from 13 donors [solid bars: ∗, p < 0.05; ∗∗, p < 0.01; or n.s. (not significant) by paired Student’s t test].

FIGURE 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2.

RPA for accumulation of mRNA encoding cytokines, enzymes, and receptors. RNase protection was performed on NK cell subsets. Data are given as mean (±SD) relative (fold) difference in mRNA levels from seven donors after normalization against GAPDH. Only significant differences are indicated: ∗, p < 0.05; ∗∗, p < 0.01; ∗∗∗, p < 0.001; ND: not detected. Inset a, RPA bands of selected mRNA accumulation from a representative donor. Inset b, EMSA. Nuclear extracts from NK1 and NK2 cells, stimulated for 20 min with medium alone or IL-12, were assayed for GAS-binding activity. Results are from a representative donor out of three tested.

The overall phenotypes induced by the NK1 and NK2 priming conditions cannot be reversed in short-term cultures, as NK cells that were grown in either NK1- or NK2-inducing conditions for 8 days and then cultured in the reverse conditions for an additional 4 days retained the cytokine expression profiles established during the 8-day priming (Fig. 1⇑). However, some modulation of cytokine production was evident. In agreement with previous studies of T and NK cells (4, 7), IL-5 production by NK2 cells was partially inhibited by IL-12, whereas IL-13 production was enhanced. The production of either IL-5 or IL-13 was not increased above basal levels in NK1 cells by any of the culture conditions tested. Culturing NK cells, primed in either NK1 or NK2 conditions for an additional 4 days with IL-12, enhanced IFN-γ production in both subsets with higher levels being produced by the restimulated NK1 cells. Together, these results suggest that NK1 and NK2 cells became unresponsive to the differentiation stimulus of IL-4 and IL-12, respectively, and, in short-term culture, are stable in their patterns of cytokine production but are susceptible to the transient effects of IL-12 (8). IL-10, generally considered to be a type 2 cytokine, was produced at low to undetectable levels by both NK1 and NK2 cells during primary culture; however, the secondary stimulation with IL-12 enhanced IL-10 production in NK1 cells (Fig. 1⇑).

Memory T cells respond to IL-12 or IL-4 with a heterogeneous cytokine secretion profile (9). In contrast, clones derived from naive T cells in the presence of either IL-12 or IL-4 display a type 1 or type 2 cytokine production phenotype, respectively (9). Since there are no reliable techniques for isolating naive NK cells from peripheral blood, we examined cytokine production in NK cells isolated from cord blood and cultured under NK1 and NK2 conditions. Cord blood-derived NK1 cells produced high levels of IFN-γ, although somewhat lower than their peripheral blood counterparts, while the NK2 cells produced nearly undetectable levels of IFN-γ, IL-5, and IL-13 (Fig. 3⇓ inset). Consistent with the protein secretion data, IFN-γ intracellular staining of peripheral blood-derived NK2 cells revealed a subpopulation (15–45%) of high IFN-γ-producing NK cells, whereas IFN-γ intracellular staining in cord blood-derived NK2 cells was just above baseline (Fig. 3⇓). These data suggest that at least a portion of peripheral blood, but not cord blood, NK cells have been activated and primed in vivo for IFN-γ production, and this ability is maintained even in the NK2 growth conditions.

FIGURE 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 3.

Intracellular staining and IFN-γ production by NK cells subsets. NK subsets were stimulated for 4 h with 20 ng/ml PMA + 50 μM ionomycin and monensin followed by PE-anti-CD56 surface labeling and FITC-anti-IFN-γ intracellular staining in the absence (continuous line) or in the presence (broken line) of excess exogenous rIFN-γ. The histograms show intracellular IFN-γ staining analyzed on gated CD56+ cells. For both peripheral and cord blood, one representative donor out of three analyzed is shown. Insets show mean ± SD IFN-γ protein production by NK cells (derived from cord blood, n = 3, or from peripheral blood, n = 13) after overnight stimulation with PMA/ionomycin.

IL-12 induces cytolytic activities and transcription of cytotoxicity-associated genes, such as perforin and granzyme B, in cytotoxic T and NK cells (10). However, analysis of the cytotoxic ability of the NK cell subsets revealed no detectable differences between NK1 and NK2 populations in either perforin or granzyme mRNA levels (Fig. 2⇑). In addition, no significant difference was observed between NK1 and NK2 cell-mediated cytotoxic activity against NK-sensitive K562 cells or in redirected lysis of anti-CD16-coated P815x2 mastocytoma cells (not shown). With the exception of CD95 (Fas) Ag, which was expressed at higher levels on the NK1 than NK2 cell surface (Fig. 4⇓), no significant differences in the expression of a variety of surface proteins were observed. However, CD95 mRNA accumulation did not differ in NK1 and NK2 cells, suggesting translational or posttranslational regulation. Apoptosis, induced by either anti-CD16 cross-linking or PMA/ionomycin, and evaluated by either PI uptake or TUNEL, was more extensive in NK1 than NK2 cells (Fig. 4⇓). IL-12 has been reported to increase NK cell susceptibility to anti-CD16-induced apoptosis (11), possibly due to the ability to up-regulate CD95 expression (12).

FIGURE 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 4.

CD95 surface expression and NK cell apoptosis. Cultured NK1 and NK2 cells were stained with anti-CD95-FITC, anti-CD16 biotin/PE-Cy5 streptavidin, and anti-CD3-PE. Data in upper panels are from cells gated on CD3-negative cells from a representative donor. Cultured NK1 and NK2 cells were treated for 4 h with medium, anti-CD16, or PMA + ionomycin. These cells were stained with anti-CD56-PE and TUNEL (striped bars) or anti-CD56-FITC + 5 μg/ml PI (stippled bars) followed by flow cytometry. CD56+ gated cells were analyzed for either uptake of PI or nicked DNA by TUNEL. Data are mean (±SD) values from four donors. ∗, p < 0.05; ∗∗, p < 0.01 by Student’s t test.

The mechanism by which T cells differentiate relates, in part, to a decreased responsiveness of Th2 cells to IL-12 due to the lack of expression of the IL-12Rβ2-chain (13). Similarly, levels of IL-12Rβ2-chain mRNA were lower in NK2 than NK1 cells, while levels of IL-12Rβ1-chain mRNA were equivalent in both subsets (Fig. 2⇑). This decreased level of IL-12Rβ2 is important in light of the role of this receptor chain in generating the high-affinity binding sites necessary for IL-12 signaling (14). IL-12 ligand binding assay revealed a threefold decrease in the number of high-affinity binding sites on NK2 as compared with NK1 cells, whereas no difference in the number of low-affinity binding sites was observed (data not shown). IL-12R signaling induces a rapid phosphorylation of JAK2 and Tyk2 kinases followed by phosphorylation of STAT1, STAT3, and STAT4 (15). STAT4 phosphorylation is induced only by IL-12 and IFN-α (16). EMSAs of NK1 and NK2 nuclear extracts after IL-12 stimulation demonstrated a marked decrease in the induction of IFN-GAS binding protein in NK2 cells compared with NK1 cells (Fig. 2⇑ inset). Supershift experiments confirmed that the IL-12-inducing GAS-binding activity was primarily due to STAT4 (not shown). These results indicate that NK1 and NK2 subsets show IL-12R modulation similar to those of their T cell counterparts.

Our data demonstrate that NK cells can differentiate into cells with NK1 and NK2 phenotypes, similar to those described in T cells. The importance of NK cells in generating an appropriate Th1 response in vivo is well documented (2). It remains to be determined whether NK2 populations exist in vivo and whether they play an important role in the inflammatory outcome of infections. Because NK cells do not produce IL-4, it is unlikely that NK2 cells are directly involved in Th2 cell generation. However, NK2 cells could contribute to a general type 2 response with production of IL-5 and IL-13. Eosinophilia in patients treated with IL-2 and/or IL-4 has been associated with both elevated IL-5 and NK cell infiltration (17, 18). Recently, it has been shown that IL-5 production by NK cells contributes to eosinophil infiltration in a mouse model of allergic inflammation (19). Further studies are needed to define the exact role of NK cell subsets in inflammation.

Footnotes

  • ↵1 This work was supported by Public Health Service Grants T32-CA09171, CA10815, CA20833, CA32898, and AI34412.

  • ↵2 Address correspondence and reprint requests to Dr. Giorgio Trinchieri, Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104. E-mail address: trinchieri{at}wista.wistar.upenn.edu

  • ↵3 Abbreviations used in this paper: GM-CSF, granulocyte-macrophage CSF; LT, lymphotoxin; RPA, RNase protection assay; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; EMSA, electrophoretic mobility shift assay; GAS, gamma-activated site; PE, phycoerythrin; PI, propidium iodine; TUNEL, terminal deoxynucleotidyltransferase-mediated UTP end labeling.

  • Received July 27, 1998.
  • Accepted October 5, 1998.
  • Copyright © 1998 by The American Association of Immunologists

References

  1. ↵
    Trinchieri, G.. 1989. Biology of natural killer cells. Adv. Immunol. 47: 187
    OpenUrlCrossRefPubMed
  2. ↵
    Scharton, T. M., P. Scott. 1993. Natural killer cells are a source of interferon-γ that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major of mice. J. Exp. Med. 178: 567
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Chan, S. H., B. Perussia, J. W. Gupta, M. Kobayashi, M. Pospísil, H. A. Young, S. F. Wolf, D. Young, S. C. Clark, G. Trinchieri. 1991. Induction of IFN-γ production by NK cell stimulatory factor (NKSF): characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173: 869
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Warren, H. S., B. F. Kinnear, J. H. Phillips, L. L. Lanier. 1995. Production of IL-5 by human NK cells and regulation of IL-5 secretion by IL-4, IL-10, and IL-12. J. Immunol. 154: 5144
    OpenUrlAbstract
  5. ↵
    Szabo, S. J., N. G. Jacobson, A. S. Dighe, U. Gubler, K. M. Murphy. 1995. Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity 2: 665
    OpenUrlCrossRefPubMed
  6. ↵
    Perussia, B., C. Ramoni, I. Anegón, M. C. Cuturi, J. Faust, G. Trinchieri. 1987. Preferential proliferation of natural killer cells among peripheral blood mononuclear cells cocultured with B lymphoblastoid cell lines. Nat. Immun. Cell Growth Regul. 6: 171
    OpenUrlPubMed
  7. ↵
    Meyaard, L., E. Hovenkamp, S. A. Otto, F. Miedema. 1996. IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses. J. Immunol. 156: 2776
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Manetti, R., F. Gerosa, M. G. Giudizi, R. Biagiotti, P. Parronchi, M. Piccinni, S. Sampognaro, E. Maggi, S. Romagnani, G. Trinchieri. 1994. Interleukin-12 induces stable priming for interferon-γ production during differentiation of human T helper (Th) cells and transient IFN-γ production in established Th2 cell clones. J. Exp. Med. 179: 1273
    OpenUrlAbstract/FREE Full Text
  9. ↵
    Gerosa, F., C. Paganin, D. Peritt, F. Paiola, M. T. Scupoli, M. Aste-Amezaga, I. Frank, G. Trinchieri. 1996. Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-γ and interleukin-10. J. Exp. Med. 183: 2559
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Chehimi, J., N. M. Valiante, A. D’Andrea, M. Rengaraju, Z. Rosado, M. Kobayashi, B. Perussia, S. Wolf, S. E. Starr, G. Trinchieri. 1993. Enhancing effect of natural killer cell stimulatory factor (NKSF/IL-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells. Eur. J. Immunol. 23: 1826
    OpenUrlCrossRefPubMed
  11. ↵
    Azzoni, L., I. Anegon, B. Calabretta, B. Perussia. 1995. Ligand binding to FcγR induces c-myc-dependent apoptosis in IL-2-stimulated NK cells. J. Immunol. 154: 491
    OpenUrlAbstract
  12. ↵
    Medvedev, A. E., A. C. Johnsen, J. Haux, B. Steinkjer, K. Egeberg, D. H. Lynch, A. Sundan, T. Espevik. 1997. Regulation of Fas and Fas-ligand expression in NK cells by cytokines and the involvement of Fas-ligand in NK/LAK cell-mediated cytotoxicity. Cytokine 9: 394
    OpenUrlCrossRefPubMed
  13. ↵
    Rogge, L., L. Barberis-Maino, M. Biffi, N. Passini, D. H. Presky, U. Gubler, F. Sinigaglia. 1997. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 185: 825
    OpenUrlAbstract/FREE Full Text
  14. ↵
    Chua, A. O., V. L. Wilkinson, D. H. Presky, U. Gubler. 1995. Cloning and characterization of a mouse IL-12 receptor-β component. J. Immunol. 155: 4286
    OpenUrlAbstract
  15. ↵
    Bacon, C. M., E. F. Petricoin, III, J. R. Ortaldo, R. C. Rees, A. C. Larner, J. A. Johnston, J. J. O’Shea. 1995. IL-12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. Proc. Natl. Acad. Sci. USA 92: 7307
    OpenUrlAbstract/FREE Full Text
  16. ↵
    Cho, S. S., C. M. Bacon, C. Sudarshan, R. C. Rees, D. Finbloom, R. Pine, J. J. O’Shea. 1996. Activation of STAT4 by IL-12 and IFN-α: evidence for the involvement of ligand-induced tyrosine and serine phosphorylation. J. Immunol. 157: 4781
    OpenUrlAbstract
  17. ↵
    Ishimitsu, T., M. Torisu. 1993. The role of eosinophils in interleukin-2/lymphokine-activated killer cell therapy. Surgery 113: 192
    OpenUrlPubMed
  18. ↵
    Sosman, J. A., S. G. Fisher, C. Kefer, R. I. Fisher, T. M. Ellis. 1994. A phase I trial of continuous infusion interleukin-4 (IL-4) alone and following interleukin-2 (IL-2) in cancer patients. Ann. Oncol. 5: 447
    OpenUrlAbstract/FREE Full Text
  19. ↵
    Walker, C., J. Checkel, S. Cammisuli, P. J. Leibson, G. J. Gleich. 1998. IL-5 production by NK cells contributes to eosinophil infiltration in a mouse model of allergic inflammation. J. Immunol. 161: 1962
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

The Journal of Immunology
Vol. 161, Issue 11
1 Dec 1998
  • Table of Contents
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cutting Edge: Differentiation of Human NK Cells into NK1 and NK2 Subsets
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Cutting Edge: Differentiation of Human NK Cells into NK1 and NK2 Subsets
David Peritt, Susan Robertson, Giorgia Gri, Louise Showe, Miguel Aste-Amezaga, Giorgio Trinchieri
The Journal of Immunology December 1, 1998, 161 (11) 5821-5824;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Cutting Edge: Differentiation of Human NK Cells into NK1 and NK2 Subsets
David Peritt, Susan Robertson, Giorgia Gri, Louise Showe, Miguel Aste-Amezaga, Giorgio Trinchieri
The Journal of Immunology December 1, 1998, 161 (11) 5821-5824;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results and Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Cutting Edge: EPHB2 Is a Coreceptor for Fungal Recognition and Phosphorylation of Syk in the Dectin-1 Signaling Pathway
  • Cutting Edge: Hypoxia-Induced Ubc9 Promoter Hypermethylation Regulates IL-17 Expression in Ulcerative Colitis
  • Cutting Edge: Mouse SARS-CoV-2 Epitope Reveals Infection and Vaccine-Elicited CD8 T Cell Responses
Show more CUTTING EDGE

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • Public Access
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606